NIAID-funded study traced evolution of Malaria drug resistance in East Africa
On Aug. 24, 2023, NIAID reported that emerging resistance to common malaria treatments in Uganda could be connected…
Parkinson’s disease gene variant found in study of some people of African ancestry
On Aug. 23, 2023, a gene variant found almost exclusively in the genomes of people of African ancestry…
Scientists released the first complete sequence of a human Y chromosome
On Aug. 23. 2023, researchers co-led by University of California, Santa Cruz Assistant Professor of Biomolecular Engineering Karen…
Aspirin can help prevent a second heart attack, but most don’t take it
On Aug. 22, 2023, a study led by researchers at Washington University School of Medicine in St. Louis…
Project NextGen awarded over $1.4 billion to develop future of COVID-19 vaccines and therapeutics
On Aug. 22, 2023, the U.S. Department of Health and Human Services (HHS) announced it had awarded more…
Alberta Innovates invested $13.6 million to strengthen Alberta’s technology sector
On Aug. 22, 2023, Alberta Innovates announced that more than $13.6 million will go to 19 partners, across…
U.S. FDA approved ABRYSVO, Pfizer’s vaccine for prevention of RSV in infants through active immunization of pregnant Individuals
On Aug. 21, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO (Respiratory…
CPRIT awarded more than $49 million to Texas institutions for cancer research and prevention
On Aug. 16, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved over…
Biotechnology | Disease | HIV | Influenza | Measles | Medicine | Plague | Polio | Therapeutics | Vaccine
The United Kingdom announced the Vaccine Development and Evaluation Centre
On Aug. 7, 2023, the United Kingdom Health and Security Agency announced the Vaccine Development and Evaluation Centre…
Biotechnology | Medicine | NIH | Therapeutics
Only 1 in 5 U.S. adults with opioid use disorder received medications to treat it in 2021
On Aug. 7, 2023, a National Institute of Health supported study found that in 2021, an estimated 2.5…
U.S. FDA approved ZURZUVAE (zuranolone), the First and only oral treatment for Women with postpartum depression
On Aug. 4, 2023, Biogen and Sage Therapeutics announced that the U.S. Food and Drug Administration (FDA) had…
U.S. FDA approved Merck’s ERVEBO (Ebola Zaire Vaccine, Live) for use in children 12 months of age and older
On Aug. 3, 2023, Merck announced that the U.S. Food and Drug Administration (FDA) had approved an expanded…
BD received 510(k) clearance for COVID-19, influenza A/B, RSV molecular combination test
On Aug. 1, 2023, BD announced that the U.S. Food and Drug Administration (FDA) 510(k) had provided clearance…
Finnish Food Authority ordered all minks be put down at fur farms with diagnosed avian influenza infections
On Aug. 1, 2023, the Finnish Food Authority specified the euthanasia criteria for fur animals infected with avian…
Henrietta Lacks’ family settled lawsuit with biotech company that used her cells without consent
On Aug. 1, 2023, more than 70 years after doctors at Johns Hopkins Hospital took Henrietta Lacks’ cervical…
Emergent BioSolutions awarded 10-Year BARDA contract valued at $704 million for Ebanga treatment for Ebola
On Jul. 31, 2023, Emergent BioSolutions announced that it was awarded a 10-year contract by the Biomedical Advanced…
Scientists developed breath test that rapidly detects COVID-19 virus
On Jul. 31, 2023, scientists at Washington University in St. Louis have developed a breath test that quickly…
Biotechnology | Diagnostics | Infectious Disease | Polio | Vaccine | WHO
Circulating vaccine-derived poliovirus type 2 reported in United Republic of Tanzania and Kenya
On Jul. 28, 2023, the World Health Organization (WHO) reported circulating vaccine-derived poliovirus type 2 (cVDPV2) in the…
Feinstein Institutes researchers first to use double neural bypass to restore movement in man living with quadriplegia
On Jul. 28, 2023, in a first-of-its-kind clinical trial, bioelectronic medicine researchers, engineers and surgeons at Northwell Healthﾒs…
Biotechnology | FDA | Vaccine
U.S. FDA approved Ervebo first U.S.-licensed vaccine for prevention of Ebola virus disease
On Jul. 28, 2023, the U.S. Food and Drug Administration (FDA) approved Merck’s Ervebo, a vaccine for the…
Genome analysis of revived 46,000-year-old roundworm from Siberian permafrost revealed a novel species
On Jul. 28, 2023, researchers from the Institute of Zoology at the University of Cologne, the Max Planck…
CIRM invested $50 million in clinical-stage research
On Jul. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $50.1 million to fund clinical-stage research…
WHO reported influenza A(H5N1) identified in cats across Poland
On Jul. 27, 2023, the IHR National Focal Point of Poland notified WHO of unusual deaths in cats…
SIGA announced U.S. Government procurement orders of approximately $138 million for oral and IV TPOXX
On Jul. 27, 2023, SIGA Technologies announced that the U.S. Department of Health and Human Services exercised procurement…
Milestones in Diabetes
Milestones in Diabetes illustrates major milestones from the first administration of the hormone insulin in 1921 to a…
JAMA reported excess death rates for Republican and Democratic voters in Florida and Ohio during COVID-19 pandemic
On Jul. 24, 2023, the Journal JAMA reported there is evidence that Republican-leaning counties had higher COVID-19 death…
Biotechnology | COVID-19 | Disease | WHO
Middle East Respiratory Syndrome reported in United Arab Emirates
On Jul. 24, 2023, the United Arab Emirates (UAE), notified WHO of a case of Middle East Respiratory…
NIH released new atlas of human kidney cells to help unlock kidney disease research
On Jul. 19, 2023, the National Institute of Health announced that a nationwide research team had created the…
First case of Candida auris reported in Washington with local transmission suspected
On Jul. 19, 2023, the King County Department of Health issued a Health Advisory that Candida auris (C….
U.S. FDA approved Veklury (Remdesivir) for COVID-19 treatment in patients with Severe renal impairment
On Jul. 14, 2023, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) had approved a…